Jasper Therapeutics, Inc. (JSPR)
Develops antibody drugs to treat diseases caused by overactive mast cells.
$0.63-0.09%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-78.0%
The outlook
JSPR is trading near its 52-week lows, roughly 11% above its low point. Analyst coverage shows an average price target significantly above the current price, though current sentiment leans bearish overall. The stock is trading below its moving averages, reflecting recent downward momentum.
What’s behind the score
Price trendMixed vs its moving averages
52-week range11% of the way from its 52-week low to high
Price targetAvg target +1348% vs current price
Analyst price target
~12-month · 3 analysts$9.17average target+1348.1% vs now
Now $0.63
Low $1.50High $20.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$21.1M
52-wk high
$3.15
52-wk low
$0.32
50-day avg
$0.62
200-day avg
$1.30
Trailing P/E
—